Doximity Inc (DOCS)
24.09
-0.23
(-0.95%)
USD |
NYSE |
May 03, 16:00
24.08
-0.02
(-0.06%)
After-Hours: 20:00
Doximity Cash from Financing (TTM): -274.31M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -274.31M |
September 30, 2023 | -198.03M |
June 30, 2023 | -94.32M |
March 31, 2023 | -74.46M |
December 31, 2022 | -58.21M |
September 30, 2022 | -55.19M |
Date | Value |
---|---|
June 30, 2022 | 2.27M |
March 31, 2022 | 560.42M |
December 31, 2021 | 557.76M |
September 30, 2021 | 556.29M |
June 30, 2021 | 557.36M |
March 31, 2021 | 5.407M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-274.31M
Minimum
Dec 2023
560.42M
Maximum
Mar 2022
123.75M
Average
-26.46M
Median
Cash from Financing (TTM) Benchmarks
Sharecare Inc | -11.73M |
GoodRx Holdings Inc | -167.40M |
Privia Health Group Inc | 3.705M |
GeneDx Holdings Corp | 53.14M |
Definitive Healthcare Corp | -25.58M |